期刊文献+

尖锐湿疣合并免疫缺陷性疾病28例临床分析 被引量:3

Clinical Analysis of Condyloma Acuminatum Patients with Impairment of Immunologic Function
下载PDF
导出
摘要 目的:研究合并免疫缺陷性疾病尖锐湿疣(CA)患者的临床及复发情况。方法:回顾性分析28例合并系统性红斑狼疮、肾移植术后、糖尿病的尖锐湿疣患者的临床资料。结果:合并免疫缺陷性疾病患者文化程度较单纯尖锐湿疣患者低,复发率高,且疣体体积增大(P<0.05)。多因素分析结果显示文化程度、合并免疫缺陷性疾病、发病时间是CA复发的独立危险因素。结论:加强性知识教育,控制免疫缺陷性疾病,早期治疗对降低合并免疫缺陷性疾病的尖锐湿疣患者高复发率有一定作用。 Objective: To study the recurrence rate of condyloma acuminatum patients with impairment of immunologic function. Methods:28 cases in condyloma acuminatum patients with systemic lupus erythematosus, kidney transplantation and diabetes mellitus were analyzed retrospectively. Results:The education in the patients with impairment of immunologic function was lower than pure condyloma acuminatum patients(P〈0.05), whereas the recurrence rate and lesion volume were higher than control group( P〈 0.05). Factors predictive of the recurrence rate of condyloma acuminatum on multivariate analysis were the level of education, the onset time of condyloma acuminatum, and complicating with immune impairments.Conclusions:The study suggest that increasing the efforts for sex education, controlling immune diseases, and early therapy may play a role in reducing the recurrence rate of condyioma acuminatum.
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2007年第11期675-677,共3页 Journal of Practical Obstetrics and Gynecology
关键词 免疫缺陷性疾病 尖锐湿疣 复发率 危险因素 Impairment of immunologic function Condyloma acuminatum Recurrence rate Risk factors.
  • 相关文献

参考文献4

二级参考文献13

  • 1Cauda R,Tying SK,Grossi CE,et al.Patients with condyloma acuminatum exhibit decreased interleukin-2 and interferon gamma production and depressed natural killer activity[J].J Clin Immunol,1987,7:304-307.
  • 2Zhou J,Mcindoe A,Davis H,et al.The induction of cytotoxic T-lymphocyte precursor cells by recombinant vaccinia virus expression human papillamavirus type 16L1[J].Virology,1991,181:203-210.
  • 3Goncalves MA, Burattini MN, Donadi EA, et al. Risk factors associated with genital warts in HIV-positive Brazilian women[J].Tumori, 2003, 89(1): 9-15.
  • 4Opaneye AA. The cellular immune system in female patients with or without genital warts: a study of peripheral white blood cell components[J]. Int J STD AIDS, 1999, 10(12): 815-816.
  • 5Frazer IH. The role of the immune system in anogenital human papillomavirus[J]. Australas J Dermatol, 1998, 39 Suppl 1: S5-S7.
  • 6Avgerinou G, Georgala S, Theodoridis A, et al. Reduction of cell mediated immunity in patients with genital warts of long duration[J]. Genitourin Med, 1986, 62(6): 396-398.
  • 7Yu HC, Cho BH, Chung M J, et al. A case of giant condylomata acuminata involving anus after renal transplantation[J]. Clin Nephrol, 2003, 59(3): 235-236.
  • 8yon Krogh G, Dahlman-Ghozlan K, Syrjanen S. Potential human papillomavirus reactivation following topical corticosteroid therapy of genital lichen sclerosus and erosive lichen planus[J]. J Eur Acad Dermatol Venereol, 2002, 16(2): 130-133.
  • 9De Panfilis G, Melzani G, Mori G, et al. Relapses after treatment of external genital warts are more frequent in HIV-positive patients than in HIV-negative controls[J]. Sex Transm Dis, 2002,29(3): 121-125.
  • 10Arany I, Tyring SK, Stanley MA, et al. Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%[J]. Antiviral Res, 1999,43(1): 55-63.

共引文献45

同被引文献2

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部